Cointime

Download App
iOS & Android

SalioGen Therapeutics

company
Funding Round
Series B
Money Raised
$ 115M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Retinal Degeneration Fund - - - Detail